Park Ha Biological Technology
Skincare products and franchise services through Chinese beauty stores.
Something off on this page? Send us feedback.
Profile
Sells Park Ha skincare products through owned and franchised Chinese beauty stores, collecting franchise fees for brand authorization, training, advertising, and operating support. It pairs outsourced manufacturing with in-store trials and after-sales service, while the Cayman holding company's operating business is based in China.
Combines product sales with franchise service for the Park Ha skincare brand in China. Products span multiple skincare series and are sold through directly operated and franchised beauty stores, supported by trials, complimentary after-sales beauty services, and customer follow-up.
Drives store traffic through an online-to-offline model using social platforms, online ordering, coupons, group buying, and live promotion. Franchise services include brand authorization, training, advertising support, and operating support; product revenue also comes from direct and online customers.
Relies on third-party manufacturers for production while managing product development, sample testing, quality control, and product filings. Most offerings are ordinary cosmetics rather than medical-grade products, and the Cayman holding company's operating business, assets, stores, and revenue base remain in China.
Company facts
Key statistics
Year to date −95.9% · Average volume (30d) 1.1M
Analysts
No analyst consensus on record.
Earnings
Not reported.
Financial highlights
| 5 quarters | — | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | — | $1.2M | $642.8K | $1.3M | $628.8K | $1.3M | |
| Gross profit | — | $1.2M | $600.8K | $1.1M | $606.0K | $1.1M | |
| Operating income | — | −$19.7M | −$2.2M | −$4.4M | −$481.3K | −$962.5K | |
| Net income | — | −$19.8M | −$2.3M | −$4.5M | −$459.1K | −$918.3K | |
| Diluted EPS | — | −$270.08 | −$28.32 | −$60.88 | −$1.28 | −$1.52 | |
| Gross margin | — | 95.3% | 93.5% | 86.2% | 96.4% | 88.8% | |
| Operating margin | — | -1,591.0% | -344.8% | -344.8% | -76.5% | -76.5% |
Balance sheet, Apr 30, 2026Cash & short-term investments $5.7M · Total debt $186.3K · Total assets $7.5M · Shareholders' equity $5.4M
Dividends
No dividends on record.
Ownership
Shares outstanding 747.9K · Float 309.4K · 41.4% free float
A split settled inside the quarter being compared, so quarter-on-quarter change is not shown.
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Li (Alya) Wang · officer: COO | 187.5K | 25.07% | Form 4 | Aug 10, 2026 |
| Xiaoyan Zhu · officer: CFO | 112.8K | 15.08% | Form 4 | Aug 7, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
View detailsPeers
Not reported.